386 related articles for article (PubMed ID: 36547676)
21.
Xue XQ; Yu WJ; Shi X; Shao XL; Wang YT
Front Oncol; 2022; 12():911168. PubMed ID: 36003788
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
23. [Values of Different Evaluation Criteria of Interim
Zhu LT; Cen XN; Ou JP; Qiu ZX; Wang LH; Liu W; Wang WS; Dong YJ; Liang ZY; Wang MJ; Xu WL; Sun YH; Wang Q; Yin Y; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):431-437. PubMed ID: 28446288
[TBL] [Abstract][Full Text] [Related]
24. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.
Nie P; Yang G; Wang N; Yan L; Miao W; Duan Y; Wang Y; Gong A; Zhao Y; Wu J; Zhang C; Wang M; Cui J; Yu M; Li D; Sun Y; Wang Y; Wang Z
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):217-230. PubMed ID: 32451603
[TBL] [Abstract][Full Text] [Related]
25. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.
Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L
Front Oncol; 2022; 12():894323. PubMed ID: 35800046
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of
Luo Y; Huang Z; Gao Z; Wang B; Zhang Y; Bai Y; Wu Q; Wang M
Korean J Radiol; 2024 Feb; 25(2):189-198. PubMed ID: 38288898
[TBL] [Abstract][Full Text] [Related]
27. Development and Validation of a Nomogram Based on
Yang X; Liu J; Lu X; Kan Y; Wang W; Zhang S; Liu L; Zhang H; Li J; Yang J
Front Med (Lausanne); 2021; 8():792677. PubMed ID: 35004761
[No Abstract] [Full Text] [Related]
28. Development and Validation of a Radiomics Nomogram Based on
Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
Front Oncol; 2020; 10():1042. PubMed ID: 32766134
[No Abstract] [Full Text] [Related]
29. Development and validation of an
Huang J; Li T; Tang L; Hu Y; Hu Y; Gu Y
Acad Radiol; 2024 Jun; ():. PubMed ID: 38845294
[TBL] [Abstract][Full Text] [Related]
30. An Optimal Radiomics Nomogram Based on
Feng L; Zhang S; Lu X; Yang X; Kan Y; Wang C; Zhang H; Wang W; Yang J
Acad Radiol; 2023 Oct; 30(10):2309-2320. PubMed ID: 37393177
[TBL] [Abstract][Full Text] [Related]
31. Preoperative prediction of mediastinal lymph node metastasis in non-small cell lung cancer based on
Huang Y; Jiang X; Xu H; Zhang D; Liu LN; Xia YX; Xu DK; Wu HJ; Cheng G; Shi YH
Clin Radiol; 2023 Jan; 78(1):8-17. PubMed ID: 36192203
[TBL] [Abstract][Full Text] [Related]
32.
Cui Y; Jiang Y; Deng X; Long W; Liu B; Fan W; Li Y; Zhang X
Acad Radiol; 2023 Jul; 30(7):1408-1418. PubMed ID: 36437191
[TBL] [Abstract][Full Text] [Related]
33. The role of baseline 2-[
Albano D; Calabrò A; Dondi F; Bagnasco S; Tucci A; Bertagna F
Hematol Oncol; 2024 Mar; 42(2):e3266. PubMed ID: 38444261
[TBL] [Abstract][Full Text] [Related]
34. Baseline
Aide N; Fruchart C; Nganoa C; Gac AC; Lasnon C
Eur Radiol; 2020 Aug; 30(8):4623-4632. PubMed ID: 32248365
[TBL] [Abstract][Full Text] [Related]
35. Stacking Ensemble Learning-Based [
Zhao S; Wang J; Jin C; Zhang X; Xue C; Zhou R; Zhong Y; Liu Y; He X; Zhou Y; Xu C; Zhang L; Qian W; Zhang H; Zhang X; Tian M
J Nucl Med; 2023 Oct; 64(10):1603-1609. PubMed ID: 37500261
[TBL] [Abstract][Full Text] [Related]
36. Prognostic nomogram for diffuse large B-cell lymphoma incorporating the International Prognostic Index with interim-positron emission tomography findings.
Chow A; Phillips M; Siew T; Cull G; Augustson B; Ward M; Joske D
Intern Med J; 2013 Aug; 43(8):932-9. PubMed ID: 23692386
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Ding CY; Guo Z; Sun J; Yang WP; Li TR
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
[No Abstract] [Full Text] [Related]
38. Development and validation of nomograms by radiomic features on ultrasound imaging for predicting overall survival in patients with primary nodal diffuse large B-cell lymphoma.
Deng H; Zhou Y; Lu W; Chen W; Yuan Y; Li L; Shu H; Zhang P; Ye X
Front Oncol; 2022; 12():991948. PubMed ID: 36568168
[TBL] [Abstract][Full Text] [Related]
39. Predictive Significance of a New Prognostic Score for Patients With Diffuse Large B-Cell Lymphoma in the Interim-Positron Emission Tomography Findings.
Kong Y; Qu L; Li Y; Liu D; Lv X; Han J
Medicine (Baltimore); 2016 Feb; 95(6):e2808. PubMed ID: 26871850
[TBL] [Abstract][Full Text] [Related]
40. Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer.
Jia T; Lv Q; Cai X; Ge S; Sang S; Zhang B; Yu C; Deng S
Front Oncol; 2023; 13():1210125. PubMed ID: 37576897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
